2nd Annual Advances in Immuno-Oncology USA Congress

Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology USA Congress, 8 - 9 October 2019, San Diego, USA. Join over 200 delegates from global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Over 40 presentations, case studies and panel discussions focusing on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical tools and research.

View the agenda: https://bit.ly/2vrwiwW

4 Interactive Streams:

·         Discovery of Immno-Oncology Therapies

·         Translational Immuno-Oncology

·         Preclinical Development – Screening, Assays and modelling in Immuno-Oncology

·         Immuno-Oncology Clinical Research & Trails

The conference is co-located with our well established 4th Annual Biomarkers and Precision Medicine USA Congress – Register now to benefit from the latest case studies and innovations in the field.

Free Live Webinar:

How CD8 Imaging Is Useful To Pharma Regarding Drug Research & Clinical Decision Making

Presented by Ivan Plavec, Chief Business Officer, ImaginAB

29^th March, 2019 | 5:00pm BST

Join us now: https://bit.ly/2JsKooP

For further information on the congress and to receive prices and booking details, please contact me at a.saez@oxfordglobal.co.uk or call +44 (0)1865 248 455.

• Alex Cao, Executive Director, MSD
• Omar Laterza, Executive Director, Merck
• Shahram Salek-Ardakani, Senior Director, Cancer Immunology, Pfizer

For the full line-up of speakers, view the agenda: https://bit.ly/2vrwiwW

https://bit.ly/2vrwiwW